China Health Appeals Chengde Court Ruling in Contract Dispute

MT Newswires Live
07/14

China Health (HKG:0673) filed a civil appeal against a first-instance court ruling in its contract dispute with the People's Government of Shuangluan District, Chengde City, and a local hospital, according to a Monday filing with the Hong Kong bourse.

The dispute stems from a 2015 hospital cooperation agreement that was terminated in 2021. China Health sued to recover more than 59.1 million yuan in outstanding loans and interest.

In May, the Chengde Intermediate People's Court ordered the hospital to repay 46.5 million yuan in outstanding principal plus interest, but dismissed the company's remaining claims, including those against the district government.

China Health seeks to overturn the judgment, uphold all of its original claims, and require the defendants to bear the litigation costs in both instances.

The company said the appeal argues that the court erred in determining key facts, omitted crucial evidence and misapplied the law.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10